Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective

Author: Montouchet C.  

Publisher: Informa Healthcare

ISSN: 1369-6998

Source: Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 907-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content